[go: up one dir, main page]

CN114984871B - Double-layer alginate microsphere for delivering probiotics and preparation method thereof - Google Patents

Double-layer alginate microsphere for delivering probiotics and preparation method thereof Download PDF

Info

Publication number
CN114984871B
CN114984871B CN202210397992.0A CN202210397992A CN114984871B CN 114984871 B CN114984871 B CN 114984871B CN 202210397992 A CN202210397992 A CN 202210397992A CN 114984871 B CN114984871 B CN 114984871B
Authority
CN
China
Prior art keywords
centrifuge tube
sodium alginate
aqueous solution
solution
calcium chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210397992.0A
Other languages
Chinese (zh)
Other versions
CN114984871A (en
Inventor
罗克
支菁蕾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ocean University of China
Original Assignee
Ocean University of China
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ocean University of China filed Critical Ocean University of China
Priority to CN202210397992.0A priority Critical patent/CN114984871B/en
Publication of CN114984871A publication Critical patent/CN114984871A/en
Application granted granted Critical
Publication of CN114984871B publication Critical patent/CN114984871B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/256Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/30Encapsulation of particles, e.g. foodstuff additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

本发明属于生物工程技术领域,具体涉及一种用于递送益生菌的双层海藻酸盐微球及其制备方法。本发明构建了一种用于递送益生菌的双层海藻酸盐微球体系,在离心力驱动流体流下,海藻酸钠和氯化钙溶液接触形成凝胶,合成尺寸可控制的双层微球(200‑500μm)。利用海藻酸钠将益生菌固定在微球内层,并在外层海藻酸钠溶液中添加RS3以减小凝胶的孔隙,提高了封装率和益生菌的生存活力。

Figure 202210397992

The invention belongs to the technical field of bioengineering, and in particular relates to a double-layer alginate microsphere for delivering probiotics and a preparation method thereof. The present invention constructs a double-layer alginate microsphere system for delivering probiotics. Under centrifugal force driven fluid flow, sodium alginate and calcium chloride solution contact to form a gel, and the double-layer microsphere with controllable size is synthesized ( 200‑500 μm). Sodium alginate was used to immobilize probiotics on the inner layer of microspheres, and RS3 was added to the outer layer of sodium alginate solution to reduce the porosity of the gel, which improved the encapsulation rate and the viability of probiotics.

Figure 202210397992

Description

一种用于递送益生菌的双层海藻酸盐微球及其制备方法A double-layer alginate microsphere for delivering probiotics and its preparation method

技术领域:Technical field:

本发明属于生物工程技术领域,具体涉及一种用于递送益生菌的双层海藻酸盐微球及其制备方法。The invention belongs to the technical field of bioengineering, and in particular relates to a double-layer alginate microsphere for delivering probiotics and a preparation method thereof.

背景技术:Background technique:

益生菌是一类在人体内,对宿主有益的活性微生物,可有效预防肠胃炎、腹泻、肥胖等,但它容易受到胃酸、胆汁盐、pH等条件的影响。目前最常用的保护措施是微胶囊技术,以碳水化合物、植物胶、蛋白质等物质作为壁材,对其进行保护。但不同的壁材可能存在封装率低、保护效果不佳、成本高、安全性不足等问题,并且制备的微胶囊无法控制益生菌的分布,其中分布在表面的益生菌进入人体后会更快失活,而且,通过挤压法制备的微胶囊通常具有颗粒粒径大(2-5mm)、影响口感的问题。Probiotics are a type of active microorganisms that are beneficial to the host in the human body and can effectively prevent gastroenteritis, diarrhea, obesity, etc., but they are easily affected by conditions such as gastric acid, bile salts, and pH. At present, the most commonly used protective measure is microencapsulation technology, which uses carbohydrates, vegetable gums, proteins and other substances as wall materials to protect them. However, different wall materials may have problems such as low encapsulation rate, poor protection effect, high cost, and insufficient safety, and the prepared microcapsules cannot control the distribution of probiotics, and the probiotics distributed on the surface will enter the human body faster. Inactivation, and the microcapsules prepared by the extrusion method usually have the problem of large particle size (2-5mm), which affects the mouthfeel.

海藻酸钠是一种天然存在的多糖类物质,具有无毒、成本低等优点,其水溶液具有较高的黏度,与钙离子形成的水凝胶作为一种新型的多孔材料,常用作封装、递送益生菌的壁材,但其高孔隙率的性质可能会导致对益生菌封装率的降低以及更早的泄露。因此,通常与其他物质结合使用,提高稳定性和保护能力。Sodium alginate is a naturally occurring polysaccharide, which has the advantages of non-toxicity and low cost. Its aqueous solution has a high viscosity. The hydrogel formed with calcium ions is a new type of porous material, which is often used as a packaging material. , Wall material for delivering probiotics, but its high porosity may lead to lower encapsulation rate of probiotics and earlier leakage. Therefore, it is often used in combination with other substances to increase stability and protection.

淀粉是一种天然高分子碳水化合物,是人类为了维持生命和健康,必须摄取的食物。淀粉按其消化的速度和程度可分为快消化淀粉、慢消化淀粉和抗性淀粉,抗性淀粉(RS)是指不能被小肠消化吸收的淀粉,可进入结肠提供健康益处。其中的三型抗性淀粉(RS3)是一种老化淀粉,具有高度的稳定性,对于控制血糖浓度、体重等都有效,同时,它可作为益生元,进入大肠以后成为益生菌的营养源,代谢产物对人体也有益。Starch is a natural high-molecular carbohydrate, and it is a food that human beings must ingest in order to maintain life and health. Starch can be divided into fast-digesting starch, slow-digesting starch and resistant starch according to its speed and degree of digestion. Resistant starch (RS) refers to starch that cannot be digested and absorbed by the small intestine and can enter the colon to provide health benefits. Among them, type III resistant starch (RS3) is an aged starch with a high degree of stability, which is effective for controlling blood sugar concentration and body weight. Metabolites are also beneficial to the human body.

但现有技术中关于益生菌的递送体系研究还存在一些缺点和不足,例如,藻酸盐凝胶的孔隙率较高,导致海藻酸盐基微胶囊对益生菌的包封效率不高,仅有64.4%-79%;结冷胶-黄原胶和壳聚糖包被的海藻酸钠微球的结构比较柔软,结构稳定性有待改善[LinhPhuong Taa,Erika Bujnaa,Otilia Antal,et al.Effects of various polysaccharides(alginate,carrageenan,gums,chitosan)and their combination with prebioticsaccharides(resistant starch,lactosucrose,lactulose)on the encapsulationofprobiotic bacteria Lactobacillus casei 01strain[J].International Journal ofBiological Macromolecules,2021,183:1136-1144.];采用挤压法制成的微胶囊颗粒粒径通常较大,约为2-5mm,且形状不规则,对食品的品质、口感及其在食品中的流动性造成一定影响[田文静,朱莹丹,岳林芳,等.益生菌微胶囊化研究现状[J].中国食品学报,2016,16(8):186-194.]。。However, there are still some shortcomings and deficiencies in the research on the delivery system of probiotics in the prior art. For example, the porosity of alginate gel is relatively high, resulting in low encapsulation efficiency of alginate-based microcapsules for probiotics. There are 64.4%-79%; the structure of gellan gum-xanthan gum and chitosan-coated sodium alginate microspheres is relatively soft, and the structural stability needs to be improved [LinhPhuong Taa, Erika Bujnaa, Otilia Antal, et al.Effects of various polysaccharides (alginate, carrageenan, gums, chitosan) and their combination with prebiotics carbohydrates (resistant starch, lactosucrose, lactulose) on the encapsulation of probiotic bacteria Lactobacillus casei 01 strain [J]. International Journal of Biological Macromolecules, 202 1,183:1136-1144.] The particle size of the microcapsules made by the extrusion method is usually large, about 2-5mm, and the shape is irregular, which will have a certain impact on the quality, taste and fluidity of the food [Tian Wenjing, Zhu Yingdan, Yue Linfang, et al. Research status of probiotic microencapsulation [J]. Chinese Journal of Food Science, 2016, 16(8): 186-194.]. .

发明内容:Invention content:

为解决现有技术中关于益生菌的递送体系研究还存在的一些缺点和不足,本发明构建了一种用于递送益生菌的双层海藻酸盐微球体系,在离心力驱动流体流下,海藻酸钠和氯化钙溶液接触形成凝胶,合成尺寸可控制的双层微球(200-500μm)。利用海藻酸钠将益生菌固定在微球内层,并在海藻酸钠外层中添加RS3,以此减小凝胶微球表面的孔隙,提高了封装率和益生菌的生存活力。同时,微球外层的RS3作为益生元,有利于微球内层益生菌抵达大肠后的定植。In order to solve some shortcomings and deficiencies in the research on the delivery system of probiotics in the prior art, the present invention constructs a double-layer alginate microsphere system for delivering probiotics. Under the fluid flow driven by centrifugal force, alginate Sodium and calcium chloride solutions are contacted to form a gel, and double-layer microspheres (200-500 μm) with controllable size are synthesized. Sodium alginate was used to immobilize probiotics on the inner layer of microspheres, and RS3 was added to the outer layer of sodium alginate to reduce the pores on the surface of gel microspheres, improve the encapsulation rate and the viability of probiotics. At the same time, the RS3 on the outer layer of the microspheres acts as a prebiotic, which is conducive to the colonization of the probiotics in the inner layer of the microspheres after reaching the large intestine.

为达到上述目的,本发明通过以下技术方案实现,一种用于递送益生菌的双层海藻酸盐微球的制备方法,包括下列步骤:In order to achieve the above object, the present invention is achieved through the following technical solutions, a method for preparing double-layered alginate microspheres for delivering probiotics, comprising the following steps:

(1)配置海藻酸钠-益生菌混合液;其中,海藻酸钠的作用为将益生菌固定在微粒的内层。(1) Sodium alginate-probiotic mixed liquid is prepared; wherein, the role of sodium alginate is to fix the probiotics on the inner layer of the microparticles.

(2)配置海藻酸钠-抗性淀粉混合液;其中,海藻酸钠的作用为将抗性淀粉固定在微粒的外层;添加抗性淀粉可用来填充形成的海藻酸盐微球的孔隙,进而提高封装效率,并限制胆盐等向微球中的扩散,增强对益生菌的保护作用。抗性淀粉能进入海藻酸钠基质中,使微球具有更大的硬度和稳定性,并能更好的抵抗人体胃肠对其的消化作用。抗性淀粉具有在小肠中不被消化吸收的特点,可保护凝胶微球运送到特定的部位如结肠处再发挥作用。抗性淀粉可作为益生元,进入结肠以后成为益生菌的营养源,被结肠微生物群落用作发酵基质,代谢产物对人体也有益康益处。(2) configure the sodium alginate-resistant starch mixture; wherein, the role of sodium alginate is to fix the resistant starch on the outer layer of the particle; adding resistant starch can be used to fill the pores of the formed alginate microspheres, In turn, the encapsulation efficiency is improved, and the diffusion of bile salts and the like into the microspheres is limited, so as to enhance the protective effect on probiotics. Resistant starch can enter the sodium alginate matrix, making the microspheres have greater hardness and stability, and can better resist the digestion of the human gastrointestinal tract. Resistant starch has the characteristics of not being digested and absorbed in the small intestine, which can protect the gel microspheres to be transported to specific parts such as the colon and then play a role. Resistant starch can be used as a prebiotic. After entering the colon, it becomes a nutrient source for probiotics and is used as a fermentation substrate by the colonic microbial community. The metabolites are also beneficial to the human body.

(3)配置氯化钙水溶液;其中,氯化钙中的钙离子起到耦合作用,使海藻酸钠生成凝胶微粒。(3) Calcium chloride aqueous solution is configured; wherein, the calcium ions in the calcium chloride play a coupling role to make the sodium alginate generate gel particles.

(4)凝胶造粒:在离心力1000g条件下离心10min,使海藻酸钠-益生菌水溶液和海藻酸钠水溶液均速滴入氯化钙水溶液中,浸泡至水凝胶小球完全凝固后,分离出水凝胶小球。(4) Gel granulation: Centrifuge for 10 minutes under the condition of centrifugal force 1000g, drip sodium alginate-probiotic aqueous solution and sodium alginate aqueous solution into calcium chloride aqueous solution at an even speed, soak until the hydrogel pellets are completely solidified, The hydrogel pellets were isolated.

此时海藻酸钠羧基官能团的Na+与二价阳离子Ca2+发生离子交换反应。同时海藻酸钠的羧基官能团之间交联形成网络结构,从而形成凝胶微球。At this time, the Na + of the carboxyl functional group of sodium alginate undergoes an ion exchange reaction with the divalent cation Ca 2 + . At the same time, the carboxyl functional groups of sodium alginate are cross-linked to form a network structure, thereby forming gel microspheres.

离心力主要影响微球的大小和形状,离心力越大,颗粒越小。在离心力1000g条件下,能制备颗粒较小且形状均匀的凝胶微球。但当离心力大于1000g时,海藻酸钠微粒形成“尾巴”,导致颗粒形状不规则,会影响其加入食品后的感官。Centrifugal force mainly affects the size and shape of microspheres, the greater the centrifugal force, the smaller the particle. Under the condition of centrifugal force of 1000g, gel microspheres with smaller particles and uniform shape can be prepared. However, when the centrifugal force is greater than 1000g, the sodium alginate particles form a "tail", resulting in irregular particle shapes, which will affect the sensory perception after it is added to food.

进一步的,步骤(1)为配置质量浓度为1-3%(w/v)的海藻酸钠溶液;取已活化的益生菌菌液离心并弃去上清液,并将配置好的海藻酸钠溶液加入到菌泥中,涡旋直至均匀。Further, step (1) is to configure a sodium alginate solution with a mass concentration of 1-3% (w/v); take the activated probiotic bacteria liquid and centrifuge and discard the supernatant, and prepare the prepared alginate Add the sodium solution to the sludge and vortex until homogenous.

若海藻酸钠浓度过高,会导致海藻酸钠-益生菌混合液和海藻酸钠-抗性淀粉过于黏稠,无法在离心过程中将两个混合液滴入至氯化钙溶液,进而阻止凝胶微球的形成;若海藻酸钠浓度过低,会导致溶液过稀,离心过程中形成“线状”凝胶,无法形成凝胶微球。If the concentration of sodium alginate is too high, the sodium alginate-probiotic mixture and sodium alginate-resistant starch will be too viscous, and the two mixtures cannot be dripped into the calcium chloride solution during centrifugation to prevent coagulation. The formation of gel microspheres; if the concentration of sodium alginate is too low, the solution will be too dilute, and a "thread-like" gel will be formed during centrifugation, and gel microspheres will not be formed.

进一步的,步骤(2)为配置质量浓度为1-3%(w/v)的海藻酸钠溶液;取抗性淀粉水溶液离心并弃去上清液,并将配置好的海藻酸钠溶液加入到沉淀中,涡旋直至均匀;得到抗性淀粉的最终浓度为5-30mg/mL的溶液。Further, step (2) is to configure a sodium alginate solution with a mass concentration of 1-3% (w/v); centrifuge the resistant starch aqueous solution and discard the supernatant, and add the configured sodium alginate solution Into the pellet, vortex until homogeneous; resulting in a solution with a final concentration of resistant starch of 5-30 mg/mL.

对于海藻酸钠而言,选择该浓度范围可确保海藻酸钠与氯化钙可形成凝胶微球,并能将益生菌固定在内层,获得形状更规则的微球。若海藻酸钠浓度过高,会导致溶液过于黏稠,无法在离心过程中将海藻酸钠-益生菌混合液和海藻酸钠-抗性淀粉混合液滴入至氯化钙溶液,进而阻止凝胶微球的形成;若海藻酸钠浓度过低,会导致溶液过稀,离心过程中形成“线状”凝胶,无法形成凝胶微球。For sodium alginate, choosing this concentration range can ensure that sodium alginate and calcium chloride can form gel microspheres, and can fix probiotics in the inner layer to obtain microspheres with more regular shape. If the concentration of sodium alginate is too high, the solution will be too viscous to drop the sodium alginate-probiotic mixture and sodium alginate-resistant starch mixture into the calcium chloride solution during centrifugation, thereby preventing gelation Formation of microspheres; if the concentration of sodium alginate is too low, the solution will be too dilute, and a "thread-like" gel will form during centrifugation, preventing the formation of gel microspheres.

对于抗性淀粉而言,若抗淀粉浓度过高,会影响海藻酸钠-抗性淀粉水溶液的黏度,导致凝胶微球形状不规则,甚至出现仅生成单层微球的情况;若抗性淀粉浓度过低,无法充分地填补凝胶微球外层的孔隙,降低对包埋在凝胶微球内层益生菌的保护效果。For resistant starch, if the concentration of resistant starch is too high, the viscosity of sodium alginate-resistant starch aqueous solution will be affected, resulting in irregular shape of gel microspheres, or even a single layer of microspheres; if the resistance If the concentration of starch is too low, it cannot fully fill the pores of the outer layer of the gel microspheres, and reduce the protective effect on the probiotics embedded in the inner layer of the gel microspheres.

进一步的,步骤(1)和步骤(2)离心的参数为3000-5000rpm离心5-20min。Further, the centrifugation parameters of step (1) and step (2) are centrifugation at 3000-5000rpm for 5-20min.

离心参数选择该范围可确保离心完全,弃去上清后获得菌体和抗性淀粉,用于与海藻酸钠的混合溶液的配置。若离心转速和时间过低,会导致无法分离完全,上清液中仍含有较多的菌体和抗性淀粉。Selecting this range of centrifugation parameters can ensure that the centrifugation is complete. After discarding the supernatant, bacteria and resistant starch are obtained, which are used for the configuration of the mixed solution with sodium alginate. If the centrifugation speed and time are too low, the separation will not be complete, and the supernatant still contains more bacteria and resistant starch.

进一步的,步骤(3)为配置质量浓度为5-10%(w/v)的氯化钙溶液。Further, step (3) is to configure a calcium chloride solution with a mass concentration of 5-10% (w/v).

氯化钙浓度主要影响凝胶微球的形成和凝胶网络结构的紧密程度。此浓度范围适合于形状规则、结构紧密的双层凝胶微球的制备。The concentration of calcium chloride mainly affects the formation of gel microspheres and the tightness of gel network structure. This concentration range is suitable for the preparation of double-layer gel microspheres with regular shape and compact structure.

进一步的,步骤(4)采用离心模块完成;所述离心模块包括依次嵌套、由内向外的第一离心管、第二离心管和第三离心管;第一离心管内置贯穿底部的第一针头;第二离心管底部开口,连接第二针头;第三离心管管盖设有与第二离心管管口大小匹配的开口。Further, step (4) is completed using a centrifuge module; the centrifuge module includes a first centrifuge tube, a second centrifuge tube and a third centrifuge tube that are nested in sequence from inside to outside; the first centrifuge tube is built into the first centrifuge tube that runs through the bottom. The needle; the bottom opening of the second centrifuge tube is connected to the second needle; the cap of the third centrifuge tube is provided with an opening matching the size of the second centrifuge tube.

进一步的,第一离心管为0.5mL离心管,第二离心管为1.5mL离心管,第三离心管为50mL离心管。Further, the first centrifuge tube is a 0.5mL centrifuge tube, the second centrifuge tube is a 1.5mL centrifuge tube, and the third centrifuge tube is a 50mL centrifuge tube.

进一步的,利用上述装置凝胶造粒的步骤为:向0.5mL离心管中装入步骤(1)配置的海藻酸钠-益生菌水溶液,向1.5mL离心管中装入步骤(2)配置的海藻酸钠-抗性淀粉水溶液,向50mL离心管中装入步骤(3)配置的氯化钙水溶液,使针头距氯化钙溶液液面距离为0.45-1.35cm;然后进行离心。Further, the steps of using the above-mentioned device for gel granulation are as follows: load the sodium alginate-probiotic aqueous solution configured in step (1) into a 0.5mL centrifuge tube, and load the sodium alginate-probiotic aqueous solution configured in step (2) into a 1.5mL centrifuge tube. Sodium alginate-resistant starch aqueous solution, put the calcium chloride aqueous solution configured in step (3) into a 50mL centrifuge tube, so that the distance between the needle and the liquid surface of the calcium chloride solution is 0.45-1.35cm; then centrifuge.

一种利用上述方法制备的双层海藻酸盐微球,内层为将益生菌固定于其中的凝胶网络结构,外层为孔隙中填充着抗性淀粉的凝胶网络结构,尺寸为200-500μm,从而充分保护益生菌免受外界环境的伤害。A double-layer alginate microsphere prepared by the above method, the inner layer is a gel network structure in which probiotics are fixed, the outer layer is a gel network structure filled with resistant starch in the pores, and the size is 200- 500μm, so as to fully protect the probiotics from the damage of the external environment.

本发明的有益效果在于:The beneficial effects of the present invention are:

(1)在现有技术的基础上,本发明通过改良益生菌递送体系的制备工艺,制备出双层递送体系,能将益生菌很好地固定在微球内部一定区域,并在外层加入不被小肠消化吸收的抗性淀粉,提高了对益生菌的封装效率和保护能力,使其更多地到达结肠发挥健康益处。且所用原料都具有安全无毒、成本低的特点,可用于添加到食品中。(1) On the basis of the existing technology, the present invention prepares a double-layer delivery system by improving the preparation process of the probiotic delivery system, which can well fix the probiotics in a certain area inside the microsphere, and add different probiotics to the outer layer. The resistant starch digested and absorbed by the small intestine improves the encapsulation efficiency and protection ability of probiotics, allowing them to reach the colon more to exert health benefits. Moreover, the raw materials used are safe, non-toxic and low in cost, and can be added to food.

(2)本发明制备工艺简单、易控制、能耗低,且环境友好、成本低,能实现对益生菌活性的保护作用,且生成微球形状规则、粒径较小,对口感影响较小,适宜应用到食品中。(2) The preparation process of the present invention is simple, easy to control, low in energy consumption, environmentally friendly, low in cost, can realize the protective effect on the activity of probiotics, and the generated microspheres have regular shape and small particle size, and have little influence on the mouthfeel , suitable for application in food.

附图说明Description of drawings

图1是本发明的离心模块结构示意图。Fig. 1 is a schematic structural view of the centrifuge module of the present invention.

图2是双层海藻酸盐微球的结构图。Figure 2 is a structural diagram of a double-layer alginate microsphere.

图3是海藻酸钠浓度对微球形貌的影响。其中,左图:5%(左)、3%(右)海藻酸钠微球实物图;中图:5%海藻酸钠微球显微镜图;右图:3%海藻酸钠微球显微镜图Figure 3 is the effect of sodium alginate concentration on the morphology of microspheres. Among them, left picture: 5% (left), 3% (right) sodium alginate microspheres; middle picture: microscopic picture of 5% sodium alginate microspheres; right picture: microscopic picture of 3% sodium alginate microspheres

图4是离心力对海藻酸钠微球粒径的影响。Figure 4 is the effect of centrifugal force on the particle size of sodium alginate microspheres.

图中,第一离心管1、第二离心管2、第三离心管3、第一针头4、第二针头5。In the figure, a first centrifuge tube 1 , a second centrifuge tube 2 , a third centrifuge tube 3 , a first needle 4 , and a second needle 5 .

具体实施方式:Detailed ways:

为使本发明实施例的目的、技术方案和优点更加清楚,下面对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention are clearly and completely described below. Obviously, the described embodiments are part of the embodiments of the present invention, not all Example. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.

实施例1:Example 1:

一种用于递送益生菌的双层海藻酸盐微球的制备方法,包括以下步骤:A preparation method for delivering probiotic double-layer alginate microspheres, comprising the following steps:

(1)分别称取海藻酸钠粉末,加入去离子水,配置成质量浓度为1-3%(w/v)的溶液,用装有桨式搅拌桨的直流搅拌机搅拌直至均匀;(1) Weigh the sodium alginate powder respectively, add deionized water, configure a solution with a mass concentration of 1-3% (w/v), and stir until uniform with a DC mixer equipped with a paddle-type stirring paddle;

取已活化的Enterococcus Faecium R7菌液于离心机中5000rpm离心10min,弃去上清液,并将配置好的2%(w/v)海藻酸钠溶液加入到菌泥中,涡旋直至均匀。Take the activated Enterococcus Faecium R7 bacteria solution and centrifuge at 5000rpm for 10 minutes in a centrifuge, discard the supernatant, and add the prepared 2% (w/v) sodium alginate solution to the bacteria sludge, and vortex until uniform.

(2)取抗性淀粉水溶液于离心机中5000rpm离心10min,弃去上清液,并将配置好的1%(w/v)海藻酸钠溶液加入到沉淀中,涡旋直至均匀。其中,抗性淀粉的最终浓度为5mg/mL。(2) Centrifuge the resistant starch aqueous solution at 5000 rpm for 10 minutes in a centrifuge, discard the supernatant, and add the prepared 1% (w/v) sodium alginate solution to the precipitate, and vortex until uniform. Wherein, the final concentration of resistant starch is 5 mg/mL.

(3)称取氯化钙粉末,加入去离子水,配置成质量浓度为10%(w/v)的氯化钙溶液。(3) Weigh the calcium chloride powder, add deionized water, and prepare a calcium chloride solution with a mass concentration of 10% (w/v).

(4)制备如图1的离心模块:离心模块包括依次嵌套、由内向外的第一离心管1、第二离心管2和第三离心管3;第一离心管内置贯穿底部的第一针头4;第二离心管底部开口,连接第二针头5;第一针头4针尾与第二针头5的针头相连通;第三离心管3管盖设有与第二离心管管口大小匹配的开口。将50mL的第三离心管的管盖剪出一定大小的空洞;将第二针头固定在1.5mL的第二离心管底部,离心管底部剪开小口;将第一针头插入0.5mL的第一离心管,并将两离心管嵌套组装,固定于50mL离心管盖上。(4) Prepare the centrifuge module as shown in Figure 1: the centrifuge module includes the first centrifuge tube 1, the second centrifuge tube 2 and the third centrifuge tube 3 which are nested in sequence from inside to outside; Needle 4; the bottom of the second centrifuge tube is open, connected to the second needle 5; the tail of the first needle 4 is connected to the needle of the second needle 5; the third centrifuge tube 3 cap is provided with the size of the second centrifuge tube mouth opening. Cut out a hole of a certain size in the cap of the 50mL third centrifuge tube; fix the second needle at the bottom of the 1.5mL second centrifuge tube, cut a small opening at the bottom of the centrifuge tube; insert the first needle into the 0.5mL first centrifuge tube Tube, and nested assembly of two centrifuge tubes, fixed on the 50mL centrifuge tube cover.

向0.5mL离心管中装入2%海藻酸钠-益生菌水溶液,向1.5mL离心管中装入1%海藻酸钠水溶液,向50mL离心管中装入10%氯化钙水溶液,使针头距氯化钙溶液液面保持一定距离。在离心力1000g条件下离心10min,使2%海藻酸钠-益生菌水溶液和1%海藻酸钠水溶液均速滴入10%氯化钙水溶液中,浸泡至水凝胶小球完全凝固后,分离出水凝胶小球,用去离子水冲洗后,保存于去离子水中。用光学显微镜观察其结构如图2所示。Put 2% sodium alginate-probiotic aqueous solution into a 0.5mL centrifuge tube, put 1% sodium alginate aqueous solution into a 1.5mL centrifuge tube, put 10% calcium chloride aqueous solution into a 50mL centrifuge tube, and keep the needle from The liquid level of calcium chloride solution is kept at a certain distance. Centrifuge at a centrifugal force of 1000g for 10 minutes, drop 2% sodium alginate-probiotic aqueous solution and 1% sodium alginate aqueous solution into 10% calcium chloride aqueous solution at an even speed, soak until the hydrogel beads are completely solidified, and separate the water Gel pellets were rinsed with deionized water and stored in deionized water. Its structure was observed with an optical microscope as shown in Figure 2.

使用血球计数板对离心后氯化钙溶液进行细胞计数,结果未发现有菌存在于离心后氯化钙溶液中,即表明双层海藻酸盐微球对菌的封装率可达100%。The cells of the calcium chloride solution after centrifugation were counted using a hemocytometer, and no bacteria were found in the calcium chloride solution after centrifugation, which indicated that the encapsulation rate of bacteria by double-layer alginate microspheres could reach 100%.

实施例2:Example 2:

分别配置下列三种溶液:Prepare the following three solutions respectively:

3%(w/v)海藻酸钠+益生菌水溶液;3% (w/v) sodium alginate + probiotic aqueous solution;

2%(w/v)海藻酸钠+20mg/mL抗性淀粉水溶液;2% (w/v) sodium alginate + 20mg/mL resistant starch aqueous solution;

8%(w/v)氯化钙水溶液。8% (w/v) calcium chloride in water.

其余均与实施例1相同。All the other are identical with embodiment 1.

实施例3:Example 3:

分别配置下列三种溶液:Prepare the following three solutions respectively:

1%(w/v)海藻酸钠+益生菌水溶液;1% (w/v) sodium alginate + probiotic aqueous solution;

1%(w/v)海藻酸钠+5mg/mL抗性淀粉水溶液;1% (w/v) sodium alginate + 5mg/mL resistant starch aqueous solution;

5%(w/v)氯化钙水溶液。5% (w/v) calcium chloride in water.

其余均与实施例1相同。All the other are identical with embodiment 1.

海藻酸钠浓度对微球形貌的影响如图3所示,氯化钙浓度、离心力均与实施例1相同。5%海藻酸钠制备的微球具有“尾巴”现象,这种不规则的球体结构加入食品后会影响口感,从而影响感官质量。降低海藻酸钠浓度使得溶液黏度减小,可明显改善该现象,浓度为3%时制备的微球为形状良好的球形。The influence of the concentration of sodium alginate on the morphology of the microspheres is shown in Figure 3, and the concentration of calcium chloride and the centrifugal force are the same as in Example 1. Microspheres prepared with 5% sodium alginate have a "tail" phenomenon, and this irregular sphere structure will affect the taste after being added to food, thereby affecting the sensory quality. Reducing the concentration of sodium alginate can reduce the viscosity of the solution, which can obviously improve this phenomenon. When the concentration is 3%, the prepared microspheres are spherical in good shape.

离心力对微球粒径的影响如图4所示,在海藻酸钠浓度、氯化钙浓度均与实施例1相同条件下,海藻酸钠微球的粒径随着离心力增大而减小。The effect of centrifugal force on the particle size of the microspheres is shown in Figure 4. Under the same conditions of sodium alginate concentration and calcium chloride concentration as in Example 1, the particle size of the sodium alginate microspheres decreases as the centrifugal force increases.

Claims (6)

1.一种用于递送益生菌的双层海藻酸盐微球的制备方法,其特征在于包括下列步骤:1. a preparation method for delivering the double-layer alginate microspheres of probiotics, it is characterized in that comprising the following steps: (1)配置海藻酸钠-益生菌水溶液;(1) configure sodium alginate-probiotic aqueous solution; (2)配置海藻酸钠-抗性淀粉水溶液;(2) configuring sodium alginate-resistant starch aqueous solution; (3)配置氯化钙水溶液;(3) configure calcium chloride aqueous solution; (4)凝胶造粒:在离心力1000g条件下离心10min,使海藻酸钠-益生菌水溶液和海藻酸钠水溶液均速滴入氯化钙水溶液中,浸泡至水凝胶小球完全凝固后,分离出水凝胶小球;采用离心模块完成;所述离心模块包括依次嵌套、由内向外的第一离心管、第二离心管和第三离心管;第一离心管内置贯穿底部的第一针头;第二离心管底部开口,连接第二针头;第三离心管管盖设有与第二离心管管口大小匹配的开口;(4) Gel granulation: Centrifuge for 10 minutes under the condition of centrifugal force 1000g, drip sodium alginate-probiotic aqueous solution and sodium alginate aqueous solution into calcium chloride aqueous solution at an even speed, soak until the hydrogel pellets are completely solidified, Separation of hydrogel pellets; complete with a centrifugal module; the centrifugal module includes a first centrifuge tube, a second centrifuge tube, and a third centrifuge tube that are nested in sequence from the inside to the outside; the first centrifuge tube has a built-in first centrifuge tube that runs through the bottom needle; the bottom opening of the second centrifuge tube is connected to the second needle; the third centrifuge tube cover is provided with an opening matching the size of the second centrifuge tube; 第一离心管为0.5mL离心管,第二离心管为1.5mL离心管,第三离心管为50mL离心管;The first centrifuge tube is a 0.5mL centrifuge tube, the second centrifuge tube is a 1.5mL centrifuge tube, and the third centrifuge tube is a 50mL centrifuge tube; 向0.5mL离心管中装入步骤(1)配置的海藻酸钠-益生菌水溶液,向1.5mL离心管中装入步骤(2)配置的海藻酸钠-抗性淀粉水溶液,向50mL离心管中装入步骤(3)配置的氯化钙水溶液,使针头距氯化钙溶液液面距离为0.45-1.35cm;然后进行离心。Put the sodium alginate-probiotic aqueous solution prepared in step (1) into a 0.5mL centrifuge tube, put the sodium alginate-resistant starch aqueous solution prepared in step (2) into a 1.5mL centrifuge tube, and put it into a 50mL centrifuge tube Load the calcium chloride aqueous solution configured in step (3), so that the distance between the needle and the liquid surface of the calcium chloride solution is 0.45-1.35 cm; then perform centrifugation. 2.如权利要求1所述的制备方法,其特征在于:步骤(1)为配置质量浓度为1-3%(w/v)的海藻酸钠溶液;取已活化的益生菌菌液离心并弃去上清液,并将配置好的海藻酸钠溶液加入到菌泥中,涡旋直至均匀。2. preparation method as claimed in claim 1 is characterized in that: step (1) is the sodium alginate solution that configuration mass concentration is 1-3% (w/v); Discard the supernatant, and add the prepared sodium alginate solution to the sludge, and vortex until uniform. 3.如权利要求1所述的制备方法,其特征在于:步骤(2)为配置质量浓度为1-3%(w/v)的海藻酸钠溶液;取抗性淀粉水溶液离心并弃去上清液,并将配置好的海藻酸钠溶液加入到沉淀中,涡旋直至均匀;得到抗性淀粉的最终浓度为5-30mg/mL的溶液。3. The preparation method as claimed in claim 1, characterized in that: step (2) is to configure a sodium alginate solution with a mass concentration of 1-3% (w/v); take the resistant starch aqueous solution and centrifuge and discard the upper Clear liquid, and add the prepared sodium alginate solution to the precipitate, vortex until uniform; obtain a solution with a final concentration of resistant starch of 5-30mg/mL. 4.如权利要求2或3所述的制备方法,其特征在于:离心的参数为3000-5000rpm离心5-20min。4. The preparation method according to claim 2 or 3, characterized in that: the centrifugal parameter is 3000-5000rpm for 5-20min. 5.如权利要求1所述的制备方法,其特征在于:步骤(3)为配置质量浓度为5-10%(w/v)的氯化钙溶液。5. The preparation method according to claim 1, characterized in that: step (3) is to configure a calcium chloride solution with a mass concentration of 5-10% (w/v). 6.一种权利要求1-5任一方法制备的双层海藻酸盐微球。6. A double-layer alginate microsphere prepared by any method of claim 1-5.
CN202210397992.0A 2022-04-12 2022-04-12 Double-layer alginate microsphere for delivering probiotics and preparation method thereof Active CN114984871B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210397992.0A CN114984871B (en) 2022-04-12 2022-04-12 Double-layer alginate microsphere for delivering probiotics and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210397992.0A CN114984871B (en) 2022-04-12 2022-04-12 Double-layer alginate microsphere for delivering probiotics and preparation method thereof

Publications (2)

Publication Number Publication Date
CN114984871A CN114984871A (en) 2022-09-02
CN114984871B true CN114984871B (en) 2023-05-30

Family

ID=83023731

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210397992.0A Active CN114984871B (en) 2022-04-12 2022-04-12 Double-layer alginate microsphere for delivering probiotics and preparation method thereof

Country Status (1)

Country Link
CN (1) CN114984871B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116570029A (en) * 2023-03-13 2023-08-11 青岛农业大学 Walnut oligopeptide probiotics microcapsule and preparation method thereof
CN117297099B (en) * 2023-11-07 2024-11-22 浙江大学 Preparation method of probiotic coating based on sodium alginate and metal polyphenol network
CN118525965A (en) * 2024-04-16 2024-08-23 常州姿润诗生物科技有限公司 Composite probiotics and preparation method thereof
CN118857903A (en) * 2024-09-25 2024-10-29 江苏凯基生物技术股份有限公司 A method for embedding organoids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6491102B2 (en) * 2012-11-29 2019-03-27 プロゲル プロプライアタリー リミティド Microparticles containing probiotics, crosslinkable reagents, modified proteins, polyol plasticizers and trehalose
CN104707575B (en) * 2015-03-30 2017-05-03 西南科技大学 Preparation method of magnetic core-shell alginate microsphere adsorbent
CN109619593B (en) * 2018-11-08 2022-06-10 淮阴工学院 A kind of probiotic double-layer microcapsule and preparation method thereof
CN109700781A (en) * 2019-02-25 2019-05-03 绍兴同创生物科技有限公司 A kind of probiotic microcapsule and preparation method thereof targeting enteron aisle
CN112544978B (en) * 2020-12-01 2023-10-03 上海扬彩生物科技有限公司 Microcapsule-embedded probiotics capable of being released at fixed points in intestinal tracts and preparation method thereof

Also Published As

Publication number Publication date
CN114984871A (en) 2022-09-02

Similar Documents

Publication Publication Date Title
CN114984871B (en) Double-layer alginate microsphere for delivering probiotics and preparation method thereof
CN110432496A (en) Prebiotic ball of double-walled porous micro-capsule and preparation method thereof
CN108524455B (en) Preparation method and application of calcium alginate/vaterite calcium carbonate composite microspheres with controllable pH-responsive release rate
CN114176227B (en) Sodium alginate-coated layer-by-layer self-assembled probiotic microcapsule and preparation method thereof
CN101289648B (en) Enterococcus faecium microcapsule formulation and method for preparing same
CN109700781A (en) A kind of probiotic microcapsule and preparation method thereof targeting enteron aisle
CN103751791B (en) The preparation method of the gel immobilized multilamellar capsule of a kind of chitosan composite Nano
CN107970227A (en) A kind of preparation method of casein/sodium alginate composite microcapsule
CN109007807A (en) A kind of microcapsules fruit ferment powder and preparation method thereof
CN107789332A (en) A kind of calcium carbonate/calcium alginate composite microspheres with adjustable drug release rate based on two-phase biomineralization technology
CN110547468A (en) Preparation method of probiotics microcapsule containing edible fungus oligosaccharide
CN106617094A (en) Probiotic microcapsules and its preparation method and application
CN106617093A (en) Acid-resistant, stable probiotic microcapsules, preparation method and application thereof
CN107375217A (en) A kind of calcium carbonate (poly ornithine/fucosan)4Self assembly carrier and preparation method
CN104388416A (en) Preparation method of microporous starch embedded lactic acid bacteria
CN105343883B (en) The preparation method of the compound galapectite pipe microballoon of porous calcium carbonate
CN1241552C (en) Konjaku gluocomannan-calcium alginate microball for carrying medicine and preparing method
CN112335884A (en) Novel probiotic microsphere and preparation method thereof
CN116035212A (en) Probiotic microcapsule with stress resistance and preparation method and application thereof
Wang et al. Synergistic effects of pH and nano-calcium carbonate on sodium alginate gels and their application for encapsulation, protection, delivery and yoghurt of probiotics
CN1233320C (en) Slow-releasing microball with nimoldipine and its preparing method
CN113230284A (en) Synbiotic microencapsulated preparation based on multi-dimensional crosslinking and preparation method and application thereof
Koyama et al. Evaluation of mass-transfer characteristics in alginate-membrane liquid-core capsules prepared using polyethylene glycol
CN117919194A (en) Stable probiotic capsule and preparation method thereof
CN113812518B (en) A kind of Salmonella phage microencapsulated microsphere and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant